Legal Representation
Attorney
Howard I. Sobelman
USPTO Deadlines
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Nov 14, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Nov 14, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Nov 4, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Nov 4, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Nov 4, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 12, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Feb 15, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 15, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 26, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 7, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jan 7, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 7, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 7, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jan 7, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 5, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 5, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jan 5, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Dec 21, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 9, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 11, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting public awareness of the need for acceptance, inclusion and support for people with autism and their families
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"AUTISM"